53 related articles for article (PubMed ID: 9754560)
1. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.
Lee RS; Tartour E; van der Bruggen P; Vantomme V; Joyeux I; Goud B; Fridman WH; Johannes L
Eur J Immunol; 1998 Sep; 28(9):2726-37. PubMed ID: 9754560
[TBL] [Abstract][Full Text] [Related]
2. Generation of cellular immune responses to antigenic tumor peptides.
Pietersz GA; Apostolopoulos V; McKenzie IF
Cell Mol Life Sci; 2000 Feb; 57(2):290-310. PubMed ID: 10766024
[TBL] [Abstract][Full Text] [Related]
3. Role of Globotriaosylceramide in Physiology and Pathology.
Celi AB; Goldstein J; Rosato-Siri MV; Pinto A
Front Mol Biosci; 2022; 9():813637. PubMed ID: 35372499
[TBL] [Abstract][Full Text] [Related]
4. STxB as an Antigen Delivery Tool for Mucosal Vaccination.
Tartour E; Johannes L
Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324699
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
6. The Cellular and Chemical Biology of Endocytic Trafficking and Intracellular Delivery-The GL-Lect Hypothesis.
Johannes L
Molecules; 2021 May; 26(11):. PubMed ID: 34072622
[TBL] [Abstract][Full Text] [Related]
7. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
Liu Y; Tian S; Thaker H; Dong M
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
[TBL] [Abstract][Full Text] [Related]
8. Molecular Biology of
Menge C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125
[TBL] [Abstract][Full Text] [Related]
9. The Role of Glycosphingolipids in Immune Cell Functions.
Zhang T; de Waard AA; Wuhrer M; Spaapen RM
Front Immunol; 2019; 10():90. PubMed ID: 30761148
[TBL] [Abstract][Full Text] [Related]
10. Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors.
Karaki S; Anson M; Tran T; Giusti D; Blanc C; Oudard S; Tartour E
Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27827885
[TBL] [Abstract][Full Text] [Related]
11. Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.
Umlauf BJ; Chung CY; Brown KC
Mol Ther; 2015 Jun; 23(6):1092-1102. PubMed ID: 25868400
[TBL] [Abstract][Full Text] [Related]
12. An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.
McIntosh JD; Manning K; Chokshi S; Naoumov NV; Fraser JD; Dunbar PR; Taylor JA
PLoS One; 2014; 9(4):e93598. PubMed ID: 24690680
[TBL] [Abstract][Full Text] [Related]
13. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans.
Chauvat A; Benhamouda N; Gey A; Lemoine FM; Paulie S; Carrat F; Gougeon ML; Rozenberg F; Krivine A; Cherai M; Lehmann P; Quintin-Colonna F; Launay O; Tartour E
Hum Vaccin Immunother; 2014; 10(1):104-13. PubMed ID: 24084262
[TBL] [Abstract][Full Text] [Related]
14. Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.
Sadraeian M; Ghoshoon MB; Mohkam M; Karimi Z; Rasoul-Amini S; Ghasemi Y
Virol Sin; 2013 Feb; 28(1):43-8. PubMed ID: 23329470
[TBL] [Abstract][Full Text] [Related]
15. Controlling subcellular delivery to optimize therapeutic effect.
Mossalam M; Dixon AS; Lim CS
Ther Deliv; 2010 Jul; 1(1):169-93. PubMed ID: 21113240
[TBL] [Abstract][Full Text] [Related]
16. Shiga toxins--from cell biology to biomedical applications.
Johannes L; Römer W
Nat Rev Microbiol; 2010 Feb; 8(2):105-16. PubMed ID: 20023663
[TBL] [Abstract][Full Text] [Related]
17. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
Tarragó-Trani MT; Storrie B
Adv Drug Deliv Rev; 2007 Aug; 59(8):782-97. PubMed ID: 17669543
[TBL] [Abstract][Full Text] [Related]
18. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
De Haan L; Hearn AR; Rivett AJ; Hirst TR
Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
[TBL] [Abstract][Full Text] [Related]
19. Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.
Voeten JT; Rimmelzwaan GF; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
Clin Exp Immunol; 2001 Sep; 125(3):423-31. PubMed ID: 11531950
[TBL] [Abstract][Full Text] [Related]
20. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.
Falguières T; Mallard F; Baron C; Hanau D; Lingwood C; Goud B; Salamero J; Johannes L
Mol Biol Cell; 2001 Aug; 12(8):2453-68. PubMed ID: 11514628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
